Back to search results

Single Session Narrative Therapy for Mental Health in HIV Patients

This study is testing a behavioral intervention called Single Session Narrative Therapy. This therapy aims to help adults (age 18 and older) who are patients at a specific clinic and are living with HIV, have substance use issues, or other mental health concerns. The goal is to see if this single session of therapy is acceptable and practical for patients, and how well it fits into an integrated primary care clinic. Researchers will measure success by looking at changes in your mental health using a questionnaire called the Patient Health Questionnaire-9 (PHQ-9) at the start and after one month. The study plans to enroll 60 participants, but its current recruitment status is unclear.

Study design
This is an interventional study with a planned enrollment of 60 participants. It is a pilot study to test the intervention's acceptability, feasibility, and fit.
What's involved
You would participate in a single session of narrative therapy. You would also complete research surveys and an interview, with mental health questionnaires at the start and after one month.
Compensation
Not stated in the trial record.
Follow-up
Your mental health will be assessed at the start of the study and again after one month.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06479980

Single Session Narrative Therapy Study

Recruiting
NAAges 18+InterventionalTreatment
University of Washington
~60 participants
Updated 2025-04-08 on ClinicalTrials.gov
What's tested:Single Session Narrative Therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient Health Questionnaire-9 (PHQ-9)
Measured over 0, 1 month

Conditions

Mental Health Issue
HIV
Substance Use

Explore related trials

HIV InfectionParental health issueSubstance Use

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Akansha Vaswani-Bye · PRINCIPAL_INVESTIGATOR · University of Washington

Who to contact

Akansha Vaswani-Bye, PhD
[email protected]
206-744-9346
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults (age 18 years and older) who are patients at \[Blinded\] Clinic
Have agreed to participate in the single session intervention
Ability to complete the interview and research surveys in English
Adults (age 18 years and older)
Referring providers at \[Blinded\] clinic (social worker, primary care physician, mental health professional etc.)
Ability to complete the research survey or interview in English.

Exclusion

Participants with need for urgent mental health treatment (e.g., at imminent risk of suicide or harm to others; disabling symptom presentation)
Inability to provide informed consent
Inability to provide informed consent
Non-referring providers

What this trial measures

  • Patient Health Questionnaire-9 (PHQ-9)0, 1 month

    The Patient Health Questionnaire-9 (PHQ-9) is a 9 item self-report measure used to screen for depression, diagnose it, monitor its severity, and measure treatment response. The PHQ-9 ranges from 0 to 27 points. A lower PHQ-9 total score indicates a better outcome.